Is Monocyte/HDL Ratio a Predictor of Mortality in Aortic Valve Surgery

NCT05641584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2022-12-14

No results posted yet for this study

Summary

In this study, the investigators aimed to determine whether the preoperative Monocyte/HDL ratio would be a predictor of postoperative mortality and morbidity in patients who underwent aortic valve replacement due to aortic stenosis.

Conditions

Interventions

OTHER

retrospective data review study

Patient information will be scanned retrospectively from the computer environment and patient cards. No intervention will be made to the patients.

Sponsors & Collaborators

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    lead OTHER_GOV

Principal Investigators

  • tuğba yücel, md · Bakirkoy Dr Sadi Konuk Traning Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2022-07-10
Completion
2022-07-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05641584 on ClinicalTrials.gov